PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.28%
Revenue growth similar to 3088.T's 4.45%. Walter Schloss would see if both companies share industry tailwinds.
3.84%
Gross profit growth 1.25-1.5x 3088.T's 2.66%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
-5.56%
Negative EBIT growth while 3088.T is at 20.37%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
0.34%
Operating income growth under 50% of 3088.T's 11.94%. Michael Burry would be concerned about deeper cost or sales issues.
-15.18%
Negative net income growth while 3088.T stands at 24.48%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.18%
Negative EPS growth while 3088.T is at 24.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.18%
Negative diluted EPS growth while 3088.T is at 24.44%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share change of 0.00% while 3088.T is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
48.93%
Similar 10Y revenue/share CAGR to 3088.T's 49.30%. Walter Schloss might see both firms benefiting from the same long-term demand.
63.76%
5Y revenue/share CAGR above 1.5x 3088.T's 22.22%. David Dodd would look for consistent product or market expansions fueling outperformance.
39.15%
3Y revenue/share CAGR above 1.5x 3088.T's 10.08%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
80.40%
Below 50% of 3088.T's 199.01%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
56.52%
Below 50% of 3088.T's 116.04%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
44.96%
3Y net income/share CAGR 50-75% of 3088.T's 61.23%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
137.78%
5Y equity/share CAGR above 1.5x 3088.T's 51.53%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
66.52%
3Y equity/share CAGR above 1.5x 3088.T's 30.38%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-98.55%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.93%
Inventory is declining while 3088.T stands at 4.18%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.74%
Similar asset growth to 3088.T's 0.76%. Walter Schloss finds parallel expansions or investment rates.
3.67%
1.25-1.5x 3088.T's 2.50%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-38.23%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
102.83%
SG&A growth well above 3088.T's 23.33%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.